Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Receivables - Net: 2017-2019

Historic Receivables - Net for Protagonist Therapeutics (PTGX) over the last 3 years, with Dec 2019 value amounting to $300,000.

  • Protagonist Therapeutics' Receivables - Net fell 66.67% to $100,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $100,000, marking a year-over-year decrease of 66.67%. This contributed to the annual value of $300,000 for FY2019, which is 2.91% down from last year.
  • Per Protagonist Therapeutics' latest filing, its Receivables - Net stood at $300,000 for FY2019, which was down 2.91% from $309,000 recorded in FY2018.
  • In the past 5 years, Protagonist Therapeutics' Receivables - Net ranged from a high of $309,000 in FY2018 and a low of $58,000 during FY2017.
  • For the 3-year period, Protagonist Therapeutics' Receivables - Net averaged around $222,333, with its median value being $300,000 (2019).
  • As far as peak fluctuations go, Protagonist Therapeutics' Receivables - Net soared by 432.76% in 2018, and later decreased by 2.91% in 2019.
  • Over the past 3 years, Protagonist Therapeutics' Receivables - Net (Yearly) stood at $58,000 in 2017, then surged by 432.76% to $309,000 in 2018, then dropped by 2.91% to $300,000 in 2019.